Literature DB >> 15787345

Hypercoagulability risk factors in children with minimal change disease and the protective role of protein-C activity.

Neşe Ozkayin1, Sevgi Mir, Kaan Kavakli.   

Abstract

It is believed that thrombotic activity in nephrotic syndrome is due to an imbalance between procoagulant/thrombotic and anticoagulant/antithrombotic factors in plasma. The aim of this study was to investigate the hypercoagulability risk in childhood minimal change disease and to find possible protective mechanisms with respect to hemostasis. Twenty-six children with minimal change disease were enrolled in this study. All patients were evaluated during an attack and on remission. The control group consisted of 33 healthy children. During the attack period, prothrombosis parameters, total lipid, cholesterol, fibrinogen levels and platelet count increased significantly compared to levels in the remission period. This denotes that hyperviscosity increases thrombosis tendency. In the attack period, the significant increase of prothrombin fragments 1 + 2 which shows thrombin formation and thrombin-antithrombin complex which causes prothrombin activation, are an indication of increased thrombosis risk. Five patients with lupus anticoagulant present and 7 patients with, activated protein-C resistance ratios carried an increased thrombosis risk. D-dimer level of fibrinolytic factors significantly increased during the attack period. These findings emphasize the existence of thrombotic activity causing the activation of the fibrinolytic system. The significant increase in protein-C activity in these patients represents one of the protective mechanisms against thrombosis. The decrease in tissue plasminogen activator and antiplasmin indicates the protective role of fibrinolytic activity. Consequently, an increase in the protein-C activity is one of the protective mechanisms. The fibrinolytic system also plays an important role in preventing thrombotic activity in these patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15787345     DOI: 10.1007/s11255-004-0868-3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  13 in total

1.  Lipoprotein(a) predicts the risk of thrombogenic complications in nephrotic syndrome.

Authors:  T Fujita; E Saito; H Ohi; T Yasugi; M Hatano
Journal:  Nephron       Date:  1992       Impact factor: 2.847

Review 2.  Inherited defects of the protein C anticoagulant system in childhood thrombo-embolism.

Authors:  U Nowak-Göttl; K Auberger; U Göbel; W Kreuz; R Schneppenheim; H Vielhaber; W Zenz; B Zieger
Journal:  Eur J Pediatr       Date:  1996-11       Impact factor: 3.183

3.  Hemostatic problems and thromboembolic complications in nephrotic children.

Authors:  A Citak; S Emre; A Sâirin; I Bilge; A Nayir
Journal:  Pediatr Nephrol       Date:  2000-02       Impact factor: 3.714

4.  [Thrombo-embolic disease as a complication of nephrotic syndrome in children].

Authors:  T Jarmoliński; J Zachwieja; E Bortkiewicz; J Stachowski; J Maciejewski
Journal:  Pediatr Pol       Date:  1996-05

5.  Coagulopathy of childhood nephrotic syndrome--a reappraisal of the role of natural anticoagulants and fibrinolysis.

Authors:  M M al-Mugeiren; A M Gader; S A al-Rasheed; H M Bahakim; A K al-Momen; A al-Salloum
Journal:  Haemostasis       Date:  1996 Nov-Dec

6.  Increased levels of protein C activity, protein C concentration, total and free protein S in nephrotic syndrome.

Authors:  N D Vaziri; S Alikhani; B Patel; Q Nguyen; C H Barton; E V Gonzales
Journal:  Nephron       Date:  1988       Impact factor: 2.847

7.  Hemostasis and thromboembolism in children with nephrotic syndrome: differences from adults.

Authors:  O Mehls; K Andrassy; J Koderisch; U Herzog; E Ritz
Journal:  J Pediatr       Date:  1987-06       Impact factor: 4.406

8.  Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.

Authors:  N D Vaziri; E C Gonzales; B Shayestehfar; C H Barton
Journal:  J Lab Clin Med       Date:  1994-07

9.  Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome.

Authors:  N D Vaziri; P Paule; J Toohey; E Hung; S Alikhani; R Darwish; M V Pahl
Journal:  Arch Intern Med       Date:  1984-09

10.  Thromboembolic complications in children with nephrotic syndrome. Risk and incidence.

Authors:  P F Hoyer; S Gonda; M Barthels; H P Krohn; J Brodehl
Journal:  Acta Paediatr Scand       Date:  1986-09
View more
  4 in total

1.  Low protein Z levels in children with nephrotic syndrome.

Authors:  Ozan Ozkaya; Kenan Bek; Tunc Fişgin; Yuksel Aliyazicioğlu; Sevinc Sultansuyu; Yonca Açikgöz; Davut Albayrak; Kemal Baysal
Journal:  Pediatr Nephrol       Date:  2006-06-30       Impact factor: 3.714

Review 2.  Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease.

Authors:  Bryce A Kerlin; Rose Ayoob; William E Smoyer
Journal:  Clin J Am Soc Nephrol       Date:  2012-02-16       Impact factor: 8.237

3.  Nephrotic Syndrome Complications - New and Old. Part 1.

Authors:  Ruxandra Mihaela Busuioc; Gabriel Mircescu
Journal:  Maedica (Bucur)       Date:  2022-03

Review 4.  Primary Nephrotic Syndrome in Adults as a Risk Factor for Pulmonary Embolism: An Up-to-Date Review of the Literature.

Authors:  Aibek E Mirrakhimov; Alaa M Ali; Aram Barbaryan; Suartcha Prueksaritanond; Nasir Hussain
Journal:  Int J Nephrol       Date:  2014-04-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.